Loading...
NEXGEL, Inc.
NXGLW•NASDAQ
HealthcareMedical - Instruments & Supplies
$0.25
$-0.01(-3.77%)
NEXGEL, Inc. (NXGLW) Stock Overview
Explore NEXGEL, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for NXGLWStats details for NXGLW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for NXGLWAnalyst Recommendations details for NXGLW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. It provides facemasks, undereye patches, blister shield foot care, hexagel, cracked heel repair patches, and fever patch. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was founded in 1997 and is based in Langhorne, Pennsylvania.
CEO
Mr. Adam R. Levy
Employees
19
Headquarters
2150 Cabot Boulevard West, Langhorne, PA
Founded
1970